Director Jens Holstein sold 5,000 shares of Veracyte Inc on July 16, 2024, reducing his holdings to 32,878 shares. Veracyte specializes in genomic diagnostics, providing actionable results for patient care.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing